Cypherpunk Technologies Inc. (CYPH): Shareholders' Equity
$153.51M
As of 2025-12-31
$139.32M
As of 2026-06-30
+37.6%
3-year compound annual growth
+26.9%
5-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $153.51M | +338.0% | 2026-03-16, Balance as of period end |
| 2024-12-31 | $35.05M | -41.7% | 2026-03-16, Balance as of period end |
| 2023-12-31 | $60.14M | +2.2% | 2025-03-26, Balance as of period end |
| 2022-12-31 | $58.87M | -45.4% | 2024-03-18, Balance as of period end |
| 2021-12-31 | $107.89M | +131.3% | 2023-03-24, Balance as of period end |
| 2020-12-31 | $46.65M | n/m | 2022-03-11, Balance as of period end |
| 2019-12-31 | -$1.75M | n/m | 2021-03-12, Balance as of period end |
| 2018-12-31 | $9.18M | -17.5% | 2020-03-16, Balance as of period end |
| 2017-12-31 | $11.12M | n/m | 2019-04-01, Balance as of period end |
| 2016-12-31 | -$100.23M | n/a | 2018-02-23, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Cypherpunk Technologies Inc. (CYPH) | 2025-12-31 | $153.51M | +338.0% |
| Transcode Therapeutics, Inc. (RNAZ) | 2025-12-31 | $10.34M | n/m |
| Apimeds Pharmaceuticals US, Inc. (APUS) | 2025-12-31 | $153.35M | n/m |
| Aclaris Therapeutics, Inc. (ACRS) | 2025-12-31 | $103.08M | -33.7% |
| Aquestive Therapeutics, Inc. (AQST) | 2025-12-31 | -$33.66M | n/m |
| Gyre Therapeutics, Inc. (GYRE) | 2025-12-31 | $106.03M | +67.5% |
| Climb Bio, Inc. (CLYM) | 2025-12-31 | $160.47M | -24.3% |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | 2025-12-31 | $147.50M | +3.6% |
| Eledon Pharmaceuticals, Inc. (ELDN) | 2025-12-31 | $81.08M | +29.8% |
Compare CYPH, RNAZ, APUS, ACRS side by side · Screen every company in Pharmaceutical Preparations ↗